NJ S2035 | 2020-2021 | Regular Session

Note: Carry Over of previous S3336
Note: Carry Over of previous A5101

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on March 16 2020 - 25% progression, died in chamber
Action: 2021-06-03 - Substituted by A277 (1R)
Text: Latest bill text (Amended) [HTML]

Summary

Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.

Sponsors


Roll Calls


History

DateChamberAction
2021-06-03SenateSubstituted by A277 (1R)
2021-02-09SenateReported from Senate Committee with Amendments, 2nd Reading
2020-03-16SenateIntroduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Same As/Similar To

A277 (Same As) 2021-11-08 - Approved P.L.2021, c.285.
S3336 (Carry Over) 2019-01-17 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
A5101 (Carry Over) 2019-03-05 - Introduced, Referred to Assembly Health and Senior Services Committee

Subjects


New Jersey State Sources


Bill Comments

feedback